Bank of New York Mellon Corp - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 149 filers reported holding REATA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$13,493,692
+46.0%
132,343
+30.2%
0.00%
+50.0%
Q1 2023$9,244,291
+138.7%
101,675
-0.3%
0.00%
+100.0%
Q4 2022$3,873,157
+55.1%
101,952
+2.6%
0.00%0.0%
Q3 2022$2,498,000
-11.0%
99,379
+7.7%
0.00%0.0%
Q2 2022$2,806,000
-29.0%
92,308
-23.5%
0.00%0.0%
Q1 2022$3,953,000
+26.3%
120,675
+1.6%
0.00%0.0%
Q4 2021$3,131,000
-75.1%
118,748
-5.1%
0.00%
-50.0%
Q3 2021$12,593,000
-25.3%
125,168
+5.0%
0.00%
-33.3%
Q2 2021$16,866,000
+77.9%
119,169
+25.3%
0.00%
+50.0%
Q1 2021$9,481,000
-20.4%
95,090
-1.3%
0.00%
-33.3%
Q4 2020$11,915,000
+30.7%
96,386
+3.0%
0.00%
+50.0%
Q3 2020$9,116,000
-40.6%
93,580
-4.8%
0.00%
-50.0%
Q2 2020$15,335,000
-10.6%
98,288
-17.3%
0.00%
-33.3%
Q1 2020$17,149,000
-32.2%
118,814
-3.9%
0.01%
-14.3%
Q4 2019$25,285,000
+197.6%
123,682
+16.9%
0.01%
+250.0%
Q3 2019$8,495,000
-20.7%
105,804
-6.8%
0.00%
-33.3%
Q2 2019$10,712,000
+20.8%
113,539
+9.4%
0.00%
+50.0%
Q1 2019$8,870,000
+75.7%
103,784
+15.3%
0.00%0.0%
Q4 2018$5,049,000
-34.9%
90,002
-5.1%
0.00%0.0%
Q3 2018$7,758,000
+238.2%
94,881
+44.7%
0.00%
+100.0%
Q2 2018$2,294,000
+127.8%
65,587
+33.5%
0.00%
Q1 2018$1,007,000
-24.6%
49,114
+4.1%
0.00%
Q4 2017$1,336,000
-4.0%
47,164
+5.5%
0.00%
Q3 2017$1,391,000
+29.5%
44,703
+31.6%
0.00%
Q2 2017$1,074,000
+113.5%
33,959
+52.9%
0.00%
Q1 2017$503,000
+22.4%
22,213
+18.1%
0.00%
Q4 2016$411,000
+0.2%
18,806
+20.8%
0.00%
Q3 2016$410,000
+88.9%
15,570
+41.9%
0.00%
Q2 2016$217,00010,9710.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders